Drug NIRMATRELVIR Molecule

Drug NIRMATRELVIR Molecule 3D model

Description

On December 22, 2021, FDA approved Paxlovid, which consists of NIRMATRELVIR as the First Oral Antiviral for Treatment of COVID-19

The 3D model was created on real mesh accurately (quad) Objects/geometries were named for easy finding & selecting Render was made in 3Ds Max & Vray

For printing, there are .stl & .3mf (unit in cm)

I greatly appreciate you finding & choosing my products. I am looking forward to serve you more if you advise by DM.

Thank you very much.

Item rating
0 0
Drug NIRMATRELVIR Molecule
$9.00
 
Royalty Free License 
10% for Ukraine
Drug NIRMATRELVIR Molecule
$9.00
 
Royalty Free License 
10% for Ukraine
Available in these collections
Response - % in - h
3D Modeling
3D Print Modeling
Rendering
Hire meView all Designers Models

3D Model formats

Format limitations
Native
  • Autodesk 3ds Max (.max) (4 files)11.3 MBVersion: 2021Renderer: V-Ray 5Version: 2022Renderer: V-Ray 5Version: 2020Renderer: V-Ray 5Version: 2019Renderer: V-Ray 5
Exchange
  • Stereolithography (.stl)5.08 MB
  • Autodesk 3ds Max (.max) (4 files)11.3 MBVersion: 2021Renderer: V-Ray 5Version: 2022Renderer: V-Ray 5Version: 2020Renderer: V-Ray 5Version: 2019Renderer: V-Ray 5
  • Alembic (.abc)215 KB
  • 3D Manufacturing File (.3mf)3.41 MB
  • 3D Studio (.3ds)464 KB
  • OBJ (.obj, .mtl)896 KB
  • Autodesk FBX (.fbx)175 KB

3D Model details

  • Publish date2021-12-28
  • Model ID#3475393
  • Animated
  • Rigged
  • VR / AR / Low-poly
  • PBR
  • Geometry Polygon mesh
  • Polygons 49,024
  • Vertices 38,108
  • Textures
  • Materials
  • UV Mapping
  • Unwrapped UVs Unknown
  • Plugins used
  • Ready for 3D Printing
Help
Chat